Originaltitel: Vitiligo secondary to immunosuppressants: a pharmacovigilance study of the FDA Adverse Event Reporting System
A better way to browse. Learn more.
A full-screen app on your home screen with push notifications, badges and more.
Originaltitel: Vitiligo secondary to immunosuppressants: a pharmacovigilance study of the FDA Adverse Event Reporting System